GETI-B:STO
Getinge publ AB
SEKÂ 244.20
arrow_downward
-0.33%(-0.80) 1D
Sep 3, 5:29:54 PM GMT+2 · SEK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GETI-B...
Open
SEKÂ 244.50
High
SEKÂ 246.30
Low
SEKÂ 242.40
Mkt. cap
62.06B
Avg. vol.
452.47K
Volume
442.45K
Dividend
1.95%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
24.87
52-wk high
SEKÂ 248.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
Open
SEKÂ 244.50
High
SEKÂ 246.30
Low
SEKÂ 242.40
Mkt. cap
62.06B
Avg. vol.
452.47K
Volume
442.45K
Dividend
1.95%
Quarterly dividend
SEKÂ 1.19
Ex-dividend date
Apr 22, 2026
P/E ratio
24.87
52-wk high
SEKÂ 248.40
52-wk low
SEKÂ 175.90
EPS
SEKÂ 9.82
Shares outstanding
254.15M
No. of employees
12K
News stories
From web sources and news partners
AD HOC NEWS
·
3 days ago
Getinge B stock holds close to new 52-week high as Nordea cuts rating after rally
Profile
Getinge AB is a publicly traded Swedish medical technology company. The company produces and distributes medical products and equipment for the healthcare and life sciences industries. The company is divided into three business areas: Life Science, Acute Care Therapies, and Surgical Workflows. The group employs approximately 12,000 people worldwide. The CEO of the company is Mattias Perjos, and the chairman of the board is Johan Malmquist. With a sales share of around 40%, the United States is by far the most important market for the company due to significantly higher prices and margins there. China and various Western European countries follow. Wikipedia
About Getinge publ AB